Identification of postoperative adjuvant
β
Takashi Hirano; Harubumi Kato; Masahiro Maeda; Yunbo Gong; Yanning Shou; Miho Na
π
Article
π
2005
π
John Wiley and Sons
π
French
β 491 KB
## Abstract Cisplatinβbased (CDDPβbased) adjuvant chemotherapy of nonβsmall cell lung cancer (NSCLC) was reported to yield 5β15% improvement in 5βyear survival compared to complete resection alone. The importance of information concerning preselection of good responders has become increasingly evid